NCT07126795View on ClinicalTrials.gov

Magnesium Sulfate in Pediatric Burn Dressing Changes

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

December 1, 2026

Study Completion Date

January 1, 2027

Conditions
Pediatric Burns
Interventions
DRUG

magnesium sulfate

IV Magnesium Sulfate 50 mg/kg (max 2 grams) over 20 minutes given immediately prior to initiation of daily sedated dressing change

DRUG

Normal Saline (0.9% NaCl)

Normal Saline given in equivalent volume as study drug over 20 minutes, immediately prior to initiation of sedated dressing change

Trial Locations (1)

55415

Hennepin County Medical Center, Minneapolis

Sponsors
All Listed Sponsors
lead

Hennepin Healthcare Research Institute

OTHER

NCT07126795 - Magnesium Sulfate in Pediatric Burn Dressing Changes | Biotech Hunter | Biotech Hunter